Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmed A Gomaa

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Genome Biology|November 25, 2014
A CRISPR design for next-generation antimicrobialsChase L Beisel, Ahmed A Gomaa, Rodolphe Barrangou
Current Medical Science|May 28, 2021
Efficacy and Safety of Ombitasvir plus Paritaprevir, Ritonavir and Ribavirin in Non-cirrhotic Treatment-naïve and Treatment-experienced Egyptians with Chronic HCV Genotype-4 InfectionManar Ahmed, Azza E Mansey, Engy A Wahsh, et al.
Infectious Disorders Drug Targets|July 17, 2018
Real Life Egyptian Experience of Daclatasvir Plus Sofosbuvir with Ribavirin in Naïve Difficult to Treat HCV PatientsEngy A Wahsh, Amal K Hussein, Ahmed A Gomaa, et al.
Mbio|January 30, 2014
Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas systemsAhmed A Gomaa, Heidi E Klumpe, Michelle L Luo, et al.
European Journal of Gastroenterology & Hepatology|September 9, 2011
Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cellsMohie-Eldeen M Amer, Samy Z El-Sayed, Wael Abou El-Kheir, et al.
Viral Immunology|January 7, 2020
Possible Association of Elevated Plasma Levels of Growth Arrest-Specific Protein 6 and the Soluble Form of Tyrosine Kinase Receptor Axl with Low Hepatitis C Viral Load in Patients with Type 2 Diabetes MellitusRasha H Bassyouni, Ahmed A Gomaa, Essam A Hassan, et al.
Molecular Cell|April 5, 2016
Identifying and Visualizing Functional PAM Diversity across CRISPR-Cas SystemsRyan T Leenay, Kenneth R Maksimchuk, Rebecca A Slotkowski, et al.
Molecular Cell|November 7, 2014
Guide RNA functional modules direct Cas9 activity and orthogonalityAlexandra E Briner, Paul D Donohoue, Ahmed A Gomaa, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 29, 2022
The Impact of Direct-Acting Antiviral Agents on Cytomegalovirus Reactivation in Chronic Hepatitis C InfectionReham M Dawood, Ahmed A Gomaa, Mai Abd El Meguid, et al.
Expert Review of Gastroenterology & Hepatology|June 8, 2019
High SVR rate following retreatment of non-sustained virological responders to sofosbuvir based anti-HCV therapies regardless of RAS testing: A real-life multicenter studySamar K Darweesh, Kadry Elsaeed, Heba Omar, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Genome Biology|November 25, 2014
A CRISPR design for next-generation antimicrobialsChase L Beisel, Ahmed A Gomaa, Rodolphe Barrangou
Current Medical Science|May 28, 2021
Efficacy and Safety of Ombitasvir plus Paritaprevir, Ritonavir and Ribavirin in Non-cirrhotic Treatment-naïve and Treatment-experienced Egyptians with Chronic HCV Genotype-4 InfectionManar Ahmed, Azza E Mansey, Engy A Wahsh, et al.
Infectious Disorders Drug Targets|July 17, 2018
Real Life Egyptian Experience of Daclatasvir Plus Sofosbuvir with Ribavirin in Naïve Difficult to Treat HCV PatientsEngy A Wahsh, Amal K Hussein, Ahmed A Gomaa, et al.
Mbio|January 30, 2014
Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas systemsAhmed A Gomaa, Heidi E Klumpe, Michelle L Luo, et al.
European Journal of Gastroenterology & Hepatology|September 9, 2011
Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cellsMohie-Eldeen M Amer, Samy Z El-Sayed, Wael Abou El-Kheir, et al.
Viral Immunology|January 7, 2020
Possible Association of Elevated Plasma Levels of Growth Arrest-Specific Protein 6 and the Soluble Form of Tyrosine Kinase Receptor Axl with Low Hepatitis C Viral Load in Patients with Type 2 Diabetes MellitusRasha H Bassyouni, Ahmed A Gomaa, Essam A Hassan, et al.
Molecular Cell|April 5, 2016
Identifying and Visualizing Functional PAM Diversity across CRISPR-Cas SystemsRyan T Leenay, Kenneth R Maksimchuk, Rebecca A Slotkowski, et al.
Molecular Cell|November 7, 2014
Guide RNA functional modules direct Cas9 activity and orthogonalityAlexandra E Briner, Paul D Donohoue, Ahmed A Gomaa, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 29, 2022
The Impact of Direct-Acting Antiviral Agents on Cytomegalovirus Reactivation in Chronic Hepatitis C InfectionReham M Dawood, Ahmed A Gomaa, Mai Abd El Meguid, et al.
Expert Review of Gastroenterology & Hepatology|June 8, 2019
High SVR rate following retreatment of non-sustained virological responders to sofosbuvir based anti-HCV therapies regardless of RAS testing: A real-life multicenter studySamar K Darweesh, Kadry Elsaeed, Heba Omar, et al.
Pageof 1